ArticleInternational journal of clinical and experimental medicine2015

Effectiveness of inhibitor rapamycin, saracatinib, linsitinib and JNJ-38877605 against human prostate cancer cells.

Wenzhi Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.